BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
vimta labs limited stock

VIMTA LABS LIMITED Share Price

918.75 -3.04 (-0.32%)
Dec 11 2024 03:30 PM Healthcare NSE: VIMTALABS

VIMTA LABS LIMITED Share Price Update

As of the latest trading session, VIMTA LABS LIMITED share price is currently at 918.75, which is down by -3.04 from its previous closing. Today, the stock has fluctuated between 911.10 and 959.00. Over the past year, VIMTA LABS LIMITED has achieved a return of 114.69 %. In the last month alone, the return has been 24.18 %. Read More...

VIMTA LABS LIMITED Performance

Day Range

Low911.10 High959.00
918.75

52 Week Range

Low 390.30 High 980.75
918.75

VIMTA LABS LIMITED Share Price

13101

524394

VIMTALABS

img img img img
No Data Available

Open Price

912.10

Prev. Close

921.80

Volume (Shares)

97133.00

Total traded value

892.40

Upper Circuit

1106.15

Lower Circuit

737.45

Note: The current prices & values are delayed, Login to your account for live updates.

VIMTA LABS LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 2036.92
PE Ratio (TTM) 43.16
Book Value / Share 152.18
Beta 0.90
ROE 13.00%
EPS (TTM) 22.90
Dividend Yield 0.22%
Net Profit Qtr (Cr) 14.59

VIMTA LABS LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 83.14
Operating Expense 62.83
Net Profit 14.59
Net Profit Margin (%) 17.54
Earnings Per Share (EPS) 6.58
EBITDA 29.63
Effective Tax Rate (%) 22.09
Particulars JUN 2024 (Values in Cr)
Revenue 73.32
Operating Expense 56.69
Net Profit 11.64
Net Profit Margin (%) 15.87
Earnings Per Share (EPS) 5.25
EBITDA 25.69
Effective Tax Rate (%) 23.39
Particulars MAR 2024 (Values in Cr)
Revenue 78.34
Operating Expense 63.28
Net Profit 11.80
Net Profit Margin (%) 15.06
Earnings Per Share (EPS) 5.34
EBITDA 24.11
Effective Tax Rate (%) 24.11
Particulars DEC 2023 (Values in Cr)
Revenue 80.10
Operating Expense 68.39
Net Profit 9.46
Net Profit Margin (%) 11.81
Earnings Per Share (EPS) 4.26
EBITDA 21.77
Effective Tax Rate (%) 24.92
Particulars SEP 2023 (Values in Cr)
Revenue 64.39
Operating Expense 56.79
Net Profit 5.92
Net Profit Margin (%) 9.19
Earnings Per Share (EPS) 2.67
EBITDA 18.86
Effective Tax Rate (%) 20.20
Particulars MAR 2024 (Values in Cr)
Revenue 283.22
Operating Expense 227.38
Net Profit 38.81
Net Profit Margin (%) 13.70
Earnings Per Share (EPS) 17.52
EBITDA 94.60
Effective Tax Rate (%) 21.74
Particulars MAR 2023 (Values in Cr)
Revenue 315.12
Operating Expense 254.75
Net Profit 47.30
Net Profit Margin (%) 15.01
Earnings Per Share (EPS) 21.37
EBITDA 97.00
Effective Tax Rate (%) 25.89
Particulars MAR 2022 (Values in Cr)
Revenue 275.98
Operating Expense 220.87
Net Profit 41.06
Net Profit Margin (%) 14.87
Earnings Per Share (EPS) 18.57
EBITDA 80.01
Effective Tax Rate (%) 25.81
Particulars MAR 2021 (Values in Cr)
Revenue 209.05
Operating Expense 181.47
Net Profit 21.26
Net Profit Margin (%) 10.16
Earnings Per Share (EPS) 9.62
EBITDA 53.51
Effective Tax Rate (%) 25.14
Particulars MAR 2020 (Values in Cr)
Revenue 180.67
Operating Expense 175.35
Net Profit 6.93
Net Profit Margin (%) 3.83
Earnings Per Share (EPS) 3.13
EBITDA 33.04
Effective Tax Rate (%) 17.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 144.20
ROE % 13.64
ROCE % 16.99
Total Debt to Total Equity 0.06
EBITDA Margin 28.53
Particulars MAR 2023 (Values in Cr)
Book Value / Share 127.33
ROE % 18.68
ROCE % 23.48
Total Debt to Total Equity 0.07
EBITDA Margin 30.91
Particulars MAR 2022 (Values in Cr)
Book Value / Share 105.83
ROE % 19.30
ROCE % 22.76
Total Debt to Total Equity 0.12
EBITDA Margin 28.93
Particulars MAR 2021 (Values in Cr)
Book Value / Share 87.92
ROE % 11.66
ROCE % 13.58
Total Debt to Total Equity 0.17
EBITDA Margin 25.53
Particulars MAR 2020 (Values in Cr)
Book Value / Share 78.19
ROE % 3.96
ROCE % 5.58
Total Debt to Total Equity 0.19
EBITDA Margin 18.24
Particulars MAR 2024 (Values in Cr)
Book Value / Share 142.67
ROE % 13.00
ROCE % 16.22
Total Debt to Total Equity 0.06
EBITDA Margin 28.01
Particulars MAR 2023 (Values in Cr)
Book Value / Share 126.79
ROE % 18.40
ROCE % 23.15
Total Debt to Total Equity 0.07
EBITDA Margin 30.79
Particulars MAR 2022 (Values in Cr)
Book Value / Share 105.68
ROE % 19.19
ROCE % 22.69
Total Debt to Total Equity 0.11
EBITDA Margin 28.99
Particulars MAR 2021 (Values in Cr)
Book Value / Share 87.89
ROE % 11.58
ROCE % 13.56
Total Debt to Total Equity 0.17
EBITDA Margin 25.59
Particulars MAR 2020 (Values in Cr)
Book Value / Share 78.23
ROE % 4.02
ROCE % 5.74
Total Debt to Total Equity 0.17
EBITDA Margin 18.29
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 25.78
Total Assets 400.05
Total Liabilities 400.05
Total Equity 319.69
Share Outstanding 22170583
Price to Book Ratio 3.12
Return on Assets (%) 10.25
Return on Capital (%) 12.1
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 39.77
Total Assets 362.32
Total Liabilities 362.32
Total Equity 281.78
Share Outstanding 22128989
Price to Book Ratio 2.48
Return on Assets (%) 13.29
Return on Capital (%) 16.23
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 11.41
Total Assets 307.19
Total Liabilities 307.19
Total Equity 233.98
Share Outstanding 22107810
Price to Book Ratio 2.98
Return on Assets (%) 13.45
Return on Capital (%) 16.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.79
Total Assets 274.35
Total Liabilities 274.35
Total Equity 194.38
Share Outstanding 22107810
Price to Book Ratio 1.83
Return on Assets (%) 7.80
Return on Capital (%) 9.52
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 6.67
Total Assets 245.76
Total Liabilities 245.76
Total Equity 172.87
Share Outstanding 22107810
Price to Book Ratio 0.76
Return on Assets (%) 2.78
Return on Capital (%) 3.49
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 24.43
Total Assets 396.00
Total Liabilities 396.00
Total Equity 316.29
Share Outstanding 22170583
Price to Book Ratio 3.12
Return on Assets (%) 9.79
Return on Capital (%) 11.57
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 38.82
Total Assets 360.47
Total Liabilities 360.47
Total Equity 280.58
Share Outstanding 22128989
Price to Book Ratio 2.48
Return on Assets (%) 13.12
Return on Capital (%) 16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 11.27
Total Assets 306.23
Total Liabilities 306.23
Total Equity 233.64
Share Outstanding 22107810
Price to Book Ratio 2.98
Return on Assets (%) 13.40
Return on Capital (%) 16.25
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.61
Total Assets 273.07
Total Liabilities 273.07
Total Equity 194.31
Share Outstanding 22107810
Price to Book Ratio 1.83
Return on Assets (%) 7.78
Return on Capital (%) 9.49
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 6.65
Total Assets 244.53
Total Liabilities 244.53
Total Equity 172.95
Share Outstanding 22107810
Price to Book Ratio 0.76
Return on Assets (%) 2.83
Return on Capital (%) 3.55
Particulars MAR 2024 (Values in Cr)
Net Income 54.48
Cash from Operations 76.36
Cash from Investing -76.04
Cash from Financing -1.90
Net change in Cash -17.05
Free Cash Flow 152.69
Particulars MAR 2023 (Values in Cr)
Net Income 64.99
Cash from Operations 100.46
Cash from Investing -57.25
Cash from Financing -10.98
Net change in Cash 19.70
Free Cash Flow 148.28
Particulars MAR 2022 (Values in Cr)
Net Income 55.68
Cash from Operations 75.70
Cash from Investing -37.84
Cash from Financing -16.61
Net change in Cash 4.60
Free Cash Flow 105.49
Particulars MAR 2021 (Values in Cr)
Net Income 28.54
Cash from Operations 44.39
Cash from Investing -31.92
Cash from Financing -4.57
Net change in Cash 0.68
Free Cash Flow 77.47
Particulars MAR 2020 (Values in Cr)
Net Income 8.27
Cash from Operations 30.53
Cash from Investing -20.84
Cash from Financing -0.66
Net change in Cash 2.83
Free Cash Flow 46.33
Particulars MAR 2024 (Values in Cr)
Net Income 51.53
Cash from Operations 73.86
Cash from Investing -74.60
Cash from Financing -1.90
Net change in Cash -17.44
Free Cash Flow 149.02
Particulars MAR 2023 (Values in Cr)
Net Income 63.83
Cash from Operations 98.74
Cash from Investing -56.92
Cash from Financing -10.66
Net change in Cash 18.92
Free Cash Flow 146.52
Particulars MAR 2022 (Values in Cr)
Net Income 55.34
Cash from Operations 75.24
Cash from Investing -37.88
Cash from Financing -16.14
Net change in Cash 4.64
Free Cash Flow 104.96
Particulars MAR 2021 (Values in Cr)
Net Income 28.39
Cash from Operations 44.17
Cash from Investing -31.87
Cash from Financing -4.57
Net change in Cash 0.52
Free Cash Flow 76.83
Particulars MAR 2020 (Values in Cr)
Net Income 8.34
Cash from Operations 30.42
Cash from Investing -20.09
Cash from Financing -1.45
Net change in Cash 2.81
Free Cash Flow 44.64
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7256.20 88.19 13.92 104333.02 5286.00 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 62.73 0.00 3.94 117.57 44.00 / 107.94
SHREE PACETRONIX LTD. 118.35 19.06 3.17 42.60 106.00 / 268.50
TRANSGENE BIOTEK LTD. 7.49 0.00 5.23 56.75 5.79 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7256.20 92.91 12.73 104333.02 5286.00 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 56.18 0.00 -30.09 41.97 29.25 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5366.00 29.10 6.02 5870.40 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 922.40
  • 26 Days 810.60
  • 10 Days 915.70
  • 50 Days 725.80
  • 12 Days 895.40
  • 100 Days 660.00
  • 20 Days 857.40
  • 200 Days 501.30
917.95
PIVOT
First Resistance 932.85
Second Resistance 943.90
Third Resistance 958.80
First Support 906.90
Second Support 892.00
Third Support 880.95
RSI 72.04
MACD 84.84
Commodity Channel Index (CCI) 65.94
ADX 69.89
Williams % R -23.29

Over 1 Month

down

24.18

Over 3 Months

down

44.41

Over 6 Months

down

87.81

Over 1 Year

down

114.69

Over 3 Years

down

30.49

Over 5 Years

down

58.29

VIMTA LABS LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

VIMTA LABS LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
59.79
Promoter Holdings
36.89
FII
3.3
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Eurofins Analytical Services India Pvt Ltd Public Shareholding 4403668.0 19.86
Sivalinga Prasad Vasireddi Shareholding of Promoter and Promoter Group 2598525.0 11.72
Lcgc Chromatography Solutions Private Limited Public Shareholding 2083175.0 9.4
Vangal Harriman Shareholding of Promoter and Promoter Group 1777893.0 8.02
Vasireddi Veerabhadra Prasad Shareholding of Promoter and Promoter Group 1463515.0 6.6
Praveena Vasireddi Shareholding of Promoter and Promoter Group 1102535.0 4.97
Andhra Pradesh Industrial Development Corporation Limited Shareholding of Promoter and Promoter Group 590000.0 2.66
Barca Global Master Fund Lp Public Shareholding 506622.0 2.29
Harita Vasireddi Shareholding of Promoter and Promoter Group 167964.0 0.76
Sireesh Chandra Vungal Shareholding of Promoter and Promoter Group 113055.0 0.51
Sudheshna Vungal Shareholding of Promoter and Promoter Group 100879.0 0.46
Swarna Latha Vasireddi Shareholding of Promoter and Promoter Group 101535.0 0.46
Sujani Vasireddi Shareholding of Promoter and Promoter Group 80389.0 0.36
Vungal Rajeswari Shareholding of Promoter and Promoter Group 80725.0 0.36
Rajya Lakshmi Vasireddi Shareholding of Promoter and Promoter Group 2300.0 0.01

VIMTA LABS LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-06-21 2.0 Final 2023-06-22 Equity shares 2022-06-16 2.0 Final 2022-06-18 Equity shares 2021-06-25 2.0 Final 2021-06-28 Equity shares 2019-07-18 2.0 Final 2019-07-22 Equity shares 2018-08-14 2.0 Final 2018-08-20 Equity shares 2016-08-25 1.0 Final 2016-08-29 Equity shares 2015-08-06 1.0 Final 2015-08-10 Equity shares 2014-06-27 2.0 Final 2014-07-01 Equity shares 2013-05-23 0.6 Final 2013-05-27 Equity shares 2011-09-15 0.4 Final 2011-09-19 Equity shares 2010-09-23 0.8 Final 2010-09-27 Equity shares 2009-09-10 0.8 Final 2009-09-14 Equity shares 2008-08-28 0.8 Final 2008-09-01 Equity shares 2007-08-02 0.8 Final 2007-08-06 Equity shares 2006-06-01 0.0 Final 0001-01-01 Equity shares 2005-05-19 0.0 Final 2005-05-23 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2006-02-24 10.0 2.0 2006-03-03

Learn More About Stocks

About VIMTA LABS LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by VIMTA LABS LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Vimta Labs Ltd?

Answer Field

The share price of Vimta Labs Ltd for NSE is ₹ 918.75 and for BSE is ₹ 915.

What is the Market Cap of Vimta Labs Ltd?

Answer Field

The market cap of Vimta Labs Ltd for NSE is ₹ 20,36.92 Cr. and for BSE is ₹ 20,28.60 Cr. as of now.

What is the 52 Week High and Low of Vimta Labs Ltd?

Answer Field

The 52 Week High and Low of Vimta Labs Ltd for NSE is ₹ 980.75 and ₹ 390.30 and for BSE is ₹ 981.35 and ₹ 390.60.

How to Buy Vimta Labs Ltd share?

Answer Field

You can trade in Vimta Labs Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Vimta Labs Ltd?

Answer Field

The 1 year returns on the stock has been 114.69%.

What is the Current Share Price of Vimta Labs Ltd?

Answer Field

Vimta Labs Ltd share price is for NSE ₹ 918.75 & for BSE ₹ 915 as on Dec 11 2024 03:30 PM.

What is the Market Cap of Vimta Labs Ltd Share?

Answer Field

The market cap of Vimta Labs Ltd for NSE ₹ 20,36.92 & for BSE ₹ 20,28.60 as on Dec 11 2024 03:30 PM.

What is the P/E Ratio of Vimta Labs Ltd Share?

Answer Field

As on Dec 11 2024 03:30 PM the price-to-earnings (PE) ratio for Vimta Labs Ltd share is 43.16.

What is the PB ratio of Vimta Labs Ltd Share?

Answer Field

As on Dec 11 2024 03:30 PM, the price-to-book (PB) ratio for Vimta Labs Ltd share is 152.18.

How to Buy Vimta Labs Ltd Share?

Answer Field

You can trade in Vimta Labs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vimta Labs Ltd Share on Bajaj Broking App?

Answer Field

To buy Vimta Labs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vimta Labs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader